Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.4218
Delayed Data
As of 4:00pm ET
 +0.0074 / +1.79%
Today’s Change
0.29
Today|||52-Week Range
1.50
-63.95%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.41
Today’s open0.41
Day’s range0.41 - 0.44
Volume1,238,658
Average volume (3 months)1,540,046
Market cap$92.2M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)+13.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...+0.33+6.13%
XENEXenon Pharmaceutical...+0.38+5.80%
CRBPCorbus Pharmaceutica...+0.26+8.67%
CATBCatabasis Pharmaceut...+0.28+4.33%
Data as of 4:00pm ET, 05/31/2016

Financials

Next reporting dateJuly 11, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Partner Offers

Search for Jobs